Cardiff Oncology (CRDF) Receivables (2016 - 2025)
Historic Receivables for Cardiff Oncology (CRDF) over the last 16 years, with Q3 2025 value amounting to $254000.0.
- Cardiff Oncology's Receivables fell 5889.97% to $254000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $254000.0, marking a year-over-year decrease of 5889.97%. This contributed to the annual value of $1.2 million for FY2024, which is 3209.46% up from last year.
- Latest data reveals that Cardiff Oncology reported Receivables of $254000.0 as of Q3 2025, which was down 5889.97% from $526000.0 recorded in Q2 2025.
- In the past 5 years, Cardiff Oncology's Receivables ranged from a high of $1.3 million in Q4 2022 and a low of $161000.0 during Q2 2023
- Over the past 5 years, Cardiff Oncology's median Receivables value was $451000.0 (recorded in 2024), while the average stood at $533789.5.
- Its Receivables has fluctuated over the past 5 years, first crashed by 7078.04% in 2023, then soared by 21212.12% in 2024.
- Quarter analysis of 5 years shows Cardiff Oncology's Receivables stood at $535000.0 in 2021, then soared by 137.57% to $1.3 million in 2022, then tumbled by 30.13% to $888000.0 in 2023, then skyrocketed by 32.09% to $1.2 million in 2024, then tumbled by 78.35% to $254000.0 in 2025.
- Its Receivables stands at $254000.0 for Q3 2025, versus $526000.0 for Q2 2025 and $405000.0 for Q1 2025.